References
- Potempa J, Korzus E, Travis J. The serpin super-family of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994; 269: 15957–60
- Bode W, Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem 1992; 204: 433–51
- Mornex J F, Chytil-Weir A, Martinet Y, Courtney M, LeCocq J P, Crystal R G. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Invest 1986; 77: 1952–61
- Stein P E, Carrell R W. What do dysfunctional serpins tell us about molecular mobility and disease. Nat Struct Biol 1995; 2: 96–113
- Carrell R, Travis J. Alpha-1-antitrypsin and the serpins: variation and countervariation. Trends Biochem Sci 1985; 10: 20–4
- Kalsheker N A. Molecular pathology of alpha-1-antitrypsin deficiency and its significance to clinical medicine. Q J Med 1994; 84: 653–8
- Wright H T, Scarsdale J N. Structural basis for the serpin inhibitor activity. Proteins: structure, function, and genetics. 1995; 22: 210–25
- Mast A E, Enghild J J, Pizzo S V, Salvesen G. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha-1-proteinase inhibitor, alpha-1-anticymotrypsin, antitrombin III, alpha-2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 1991; 30: 1723–30
- Lawrence D A, Olson S T, Palaniappan S, Ginsburg D. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J Biol Chem 1994; 269: 27657–62
- Perlmutter D H, Glover G I, Rivetna M, Schasteen C S, Fallon R J. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc Natl Acad Sci 1990; 87: 3753–7
- Pratt C W, Church F C, Pizzo S V. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors. Arch Biochem Biophys 1988; 262: 111–17
- Kounnas M Z, Church F C, Argraves W S, Strickland D K. Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha-1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein. J Biol Chem 1996; 271: 6523–9
- Herz J, Goldstein J L, Strickland D K, Ho K Y, Brown M S. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha-2-macroglobulin receptor. J Biol Chem 1991; 266: 21232–8
- Moestrup S K, Gliemann J, Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 1992; 269: 375–82
- Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994; 63: 601–37
- Slunga L, Johnson O, Dahlen G H, Eriksson S. Lipoprotein (a) and acute-phase proteins in acute myocardial infarction. Scand J Clin Lab Invest 1992; 52: 95–101
- Vitols S, Björkholm M, Gahrton G, Peterson C. Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein receptor activity in tumor cells: evidence from studies in patients with leukaemia. Lancet 1985; 1150–3
- Galloway M J, Mackie M J, McVerry B A. Elastase-alpha-1-antitrypsin complexes in acute leukaemia. Thromb Res 1985; 38: 311–20
- Joslin G, Griffin G L, August A M, Adams S, Fallon R J, Perlmutter D H. The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1-antitrypsin-elastase complexes and amyloid β peptide. J Clin Invest 1992; 90: 1150–4
- Dangler R, Lottspeich F, Oberthur W, Mast A E, Emmerich B. Limited proteolysis of alpha-1-proteinase inhibitor (alpha 1-PI) in acute leukemia: studies on the resulting fragments and implication for the structure of the inactivated inhibitor. Biol Chem Hoppe Seyler 1995; 376: 165–72
- Franzblau A, Criqui M H. Characteristics of persons with marked hypocholesterolemia. A population-based study. J Chronic Dis 1984; 37: 387–95
- Stefansson S, Lawrence D A, Argraves W S. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2. J Biol Chem 1996; 271: 8215–20
- Janciauskiene S, Eriksson S. In vitro complex formation between cholesterol and alpha-1-proteinase inhibitor. FEBS Lett 1992; 316: 269–72
- Havel R J, Eder H A, Bragdon J H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
- Bilheimer D W, Eisenberg S, Levy R I. The metabolism of very-low-density lipoproteins. I Preliminary in vitro and in vivo observations. Biochim Biophys Acta 1972; 269: 212–21
- Salter A M, Saxton J, Brindley D. Characterization of the binding of human low-density lipoprotein to primary monolayer cultures of rat hepatocytes. Biochem J 1986; 240: 549–57
- Bierman R L, Stein O, Stein Y. Lipoprotein uptake and metabolism by aortic smooth muscle cells in tissue culture. Circ Res 1974; 35: 136–50
- Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurements with folin phenol reagents. J Biol Chem 1951; 193: 265–75
- Norusis M J. SPSS for Windows, rel. 6.0. SPSS, Chicago 1993
- Kovacs T, Kalapos M P, Mandl J, Spolarics Z, Garzo T, Antoni F. Interaction of thrombin antithrombin III and their complex with hepatocytes: comparison of the molecular components of human and mouse origin. Thromb Res 1987; 46: 875–80
- Fuchs H E, Shifman M A, Michalopoulos G, Pizzo S V. Hepatocyte receptors for antithrombin III-proteinase complexes. J Cell Biochem 1984; 24: 197–206